Free Trial
NYSE:INSP

Inspire Medical Systems (INSP) Stock Price, News & Analysis

Inspire Medical Systems logo
$60.89 -1.22 (-1.96%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Inspire Medical Systems Stock (NYSE:INSP)

Advanced

Key Stats

Today's Range
$60.39
▼
$62.54
50-Day Range
$61.93
▼
$76.85
52-Week Range
$38.91
▼
$147.03
Volume
80,550 shs
Average Volume
1.03 million shs
Market Capitalization
$1.76 billion
P/E Ratio
17.67
Dividend Yield
N/A
Price Target
$71.24
Consensus Rating
Hold

Company Overview

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy.

Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep. Patients control the system with a handheld remote, and clinicians can adjust its settings.

The U.S. Food and Drug Administration approved the Inspire system in 2014. Inspire Medical Systems markets its products in the United States and in selected international markets, including parts of Europe.

AI Generated. May Contain Errors.

Inspire Medical Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

INSP MarketRank™: 
3.429546050905 of 5 stars

Inspire Medical Systems scored higher than 69% of companies evaluated by MarketBeat, and ranked 207th out of 896 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.10, and is based on 1 strong buy rating, 3 buy ratings, 13 hold ratings, and 3 sell ratings.

  • Upside Potential

    Inspire Medical Systems has a consensus price target of $71.24, representing about 14.8% upside from its current price of $62.04.

  • Amount of Analyst Coverage

    Inspire Medical Systems has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Inspire Medical Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Inspire Medical Systems are expected to grow by 17.05% in the coming year, from $1.29 to $1.51 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inspire Medical Systems is 30.69, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.05.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inspire Medical Systems is 30.69, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.27.

  • Price to Earnings Growth Ratio

    Inspire Medical Systems has a PEG Ratio of 4.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Inspire Medical Systems has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    14.63% of the float of Inspire Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Inspire Medical Systems has a short interest ratio ("days to cover") of 6.62.
  • Change versus previous month

    Short interest in Inspire Medical Systems has recently decreased by 7.75%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Inspire Medical Systems does not currently pay a dividend.

  • Dividend Growth

    Inspire Medical Systems does not have a long track record of dividend growth.

  • News Sentiment

    Inspire Medical Systems has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Inspire Medical Systems this week, compared to 8 articles on an average week.
  • Search Interest

    3 people have searched for INSP on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 2 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inspire Medical Systems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.20% of the stock of Inspire Medical Systems is held by insiders.

  • Percentage Held by Institutions

    94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Inspire Medical Systems' insider trading history.
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INSP Stock News Headlines

A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
See More Headlines

INSP Stock Analysis - Frequently Asked Questions

Inspire Medical Systems' stock was trading at $92.20 at the start of the year. Since then, INSP shares have decreased by 32.7% and is now trading at $62.0440.

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings results on Monday, November, 2nd. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.05. The business's revenue for the quarter was down 7.9% on a year-over-year basis.
Read the conference call transcript
.

Inspire Medical Systems' Board of Directors approved a stock buyback program on Monday, August 11th 2025, which permits the company to repurchase $200 million in outstanding shares, according to EventVestor. This means that the company could buy up to 8.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's leadership believes its shares are undervalued.

Inspire Medical Systems (INSP) raised $101 million in an initial public offering on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Top institutional investors of Inspire Medical Systems include State Street Corp (4.32%), Assenagon Asset Management S.A. (2.23%), William Blair Investment Management LLC (2.21%) and Public Sector Pension Investment Board (0.34%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, Jason P Kelly, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet.
View institutional ownership trends
.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Tesla (TSLA), CrowdStrike (CRWD), Zscaler (ZS), Alibaba Group (BABA), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Company Calendar

Last Earnings
11/02/2026
Today
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:INSP
CIK
1609550
Fax
N/A
Employees
1,333
Year Founded
2007

Price Target and Rating

High Price Target
$180.00
Low Price Target
$39.00
Potential Upside/Downside
+17.7%
Consensus Rating
Hold
Rating Score (0-4)
2.10
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.44
Trailing P/E Ratio
17.59
Forward P/E Ratio
40.08
P/E Growth
4.55
Net Income
$145.42 million
Net Margins
11.43%
Pretax Margin
3.50%
Return on Equity
7.32%
Return on Assets
6.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.45
Quick Ratio
4.61

Sales & Book Value

Annual Sales
$911.98 million
Price / Sales
1.92
Cash Flow
$2.78 per share
Price / Cash Flow
21.76
Book Value
$28.55 per share
Price / Book
2.12

Miscellaneous

Outstanding Shares
28,970,000
Free Float
28,329,000
Market Cap
$1.75 billion
Optionable
Optionable
Beta
0.67

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NYSE:INSP) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners